Jump to content

20250188433. Compositions (Regeneron Pharmaceuticals, .)

From WikiPatents

COMPOSITIONS AND METHODS FOR INTERNALIZING ENZYMES

Abstract: compositions and methods for treating lysosomal storage diseases are disclosed. biotherapeutic complexes containing an internalization effector binding domain and a lysosomal replacement enzyme activity are disclosed. the biotherapeutic complexes are capable of entering cells, segregating to the lysosome, and delivering the replacement enzyme activity to the lysosome.

Inventor(s): Andrew Baik, Katherine Cygnar

CPC Classification: C12N9/2402 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media ))

Search for rejections for patent application number 20250188433


Cookies help us deliver our services. By using our services, you agree to our use of cookies.